Where it comes from
- Made in
- Fat cells only, in large amounts: it is one of the most abundant hormones in blood
- Sent out by
- Falls as fat cells enlarge; rises with weight loss and with thiazolidinedione drugs
- Acts on
- Liver (less glucose output)
- Muscle (more fat burning)
- Vessels (less inflammation)
- Heart
What it does
- Makes liver and muscle more sensitive to insulin through AMPK
- Low in obesity, type 2 diabetes and coronary disease
- Paradoxically high in heart failure and kidney failure, where it predicts worse outcomes
In medicine
- A research marker; pioglitazone works partly by raising it
- No approved medicine copies it. The hormone is an awkward drug, working as a large multimer that has to be assembled correctly, so the effort has gone into small molecules and short peptides that hit its receptors instead 2
Beyond the body’s own use
- AdipoRon, a small molecule that activates both adiponectin receptors, improved insulin sensitivity and prolonged the shortened life of obese diabetic mice; it has not been tested in people 2
- ALY688, a peptide agonist of the same receptors, has been through a phase 2b/3 trial as eye drops for dry eye disease rather than for metabolic disease
- There is nothing to swallow: adiponectin is a large protein, digested before it reaches the blood, so an “adiponectin booster” can only mean something that raises the body’s own level, as weight loss and the thiazolidinediones do
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.